Investigational Drug Information for AZD9977
✉ Email this page to a colleague
What is the drug development status for AZD9977?
AZD9977 is an investigational drug.
There have been 13 clinical trials for AZD9977.
The most recent clinical trial was a Phase 1 trial, which was initiated on January 26th 2021.
The most common disease conditions in clinical trials are Heart Failure, Renal Insufficiency, Chronic, and Kidney Diseases. The leading clinical trial sponsors are AstraZeneca, Parexel, and Quotient Sciences.
There are three US patents protecting this investigational drug and fifty-one international patents.
Summary for AZD9977
| US Patents | 3 |
| International Patents | 51 |
| US Patent Applications | 11 |
| WIPO Patent Applications | 2 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2021-01-26) |
| Vendors | 19 |
Recent Clinical Trials for AZD9977
| Title | Sponsor | Phase |
|---|---|---|
| Study to Assess the Bioavailability of Different Formulations of AZD9977 and Dapagliflozin and Influence of Food in Selected Formulations in Healthy Volunteers | Parexel | Phase 1 |
| Study to Assess the Bioavailability of Different Formulations of AZD9977 and Dapagliflozin and Influence of Food in Selected Formulations in Healthy Volunteers | AstraZeneca | Phase 1 |
| Efficacy, Safety and Tolerability of AZD9977 and Dapagliflozin in Participants With Heart Failure and Chronic Kidney Disease | AstraZeneca | Phase 2 |
Clinical Trial Summary for AZD9977
Top disease conditions for AZD9977
Top clinical trial sponsors for AZD9977
US Patents for AZD9977
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| AZD9977 | ⤷ Sign Up | Benzoxazinone amides as mineralocorticoid receptor modulators | AstraZeneca AB (Sodertalje, SE) | ⤷ Sign Up |
| AZD9977 | ⤷ Sign Up | Methods of treating heart failure with reduced ejection fraction | ASTRAZENECA AB (Sodertalje, SE) | ⤷ Sign Up |
| AZD9977 | ⤷ Sign Up | Benzoxazinone amides as mineralocorticoid receptor modulators | AstraZeneca AB (Sodertalje, SE) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for AZD9977
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| AZD9977 | Argentina | AR101036 | 2034-06-30 | ⤷ Sign Up |
| AZD9977 | Australia | AU2015282450 | 2034-06-30 | ⤷ Sign Up |
| AZD9977 | Canada | CA2953655 | 2034-06-30 | ⤷ Sign Up |
| AZD9977 | China | CN106536491 | 2034-06-30 | ⤷ Sign Up |
| AZD9977 | Cyprus | CY1121596 | 2034-06-30 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
